Larochelle F, Ross G, Rouabhia M
Département de Chirurgie, Université Laval, Québec, Canada.
Lab Invest. 1998 Sep;78(9):1089-99.
This study was conducted to investigate permanent skin replacement using heterologous (syngeneic-allogeneic) epidermal substitutes containing fewer than 5% syngeneic keratinocytes. Keratinocytes were isolated from the skin of new-born Balb/c (B) and C3H/HeN (C) mice and cocultured in different ratios: 20%B-80%C, 10%B-90%C, 5%B-95%C, and 2%B-98%C (and vice versa). After 4 to 5 days, graftable epidermal substitutes were obtained and transplanted onto adult Balb/c or C3H/HeN male mice. Recipients always received the heterografts containing the lower percentage of their own keratinocytes. On Days 15 and 30 postgrafting, all heterografts showed significant graft take (> 75%) and skin replacement compared with allografts. Regenerated tissues were well structured and well vascularized. These tissues contained only syngeneic keratinocytes. These results led us to question whether this was an active immune situation. Structural analyses revealed the presence of leukocyte infiltration that was dependent on the percentage of allogeneic keratinocytes present in the heterologous implant. However, even with the 2% syngeneic-98% allogeneic implant, infiltration was lower than with the allograft. Leukocyte phenotyping confirmed the presence of immune cells infiltrating the heterologous implants and revealed the involvement of CD8+ and CD4+ lymphocytes in this immune activation. The percentages of these two cell populations were lower than those obtained with the allografts, suggesting moderate cellular activation after each heterograft compared with the allografts. In conclusion, it is possible to generate functional skin even after 2% syngeneic-98% allogeneic heterografts; there was moderate cellular immune activation compared with the allografts.
本研究旨在探讨使用含有少于5%同基因角质形成细胞的异种(同基因-异基因)表皮替代物进行永久性皮肤替代。从新生的Balb/c(B)和C3H/HeN(C)小鼠皮肤中分离角质形成细胞,并以不同比例共培养:20%B - 80%C、10%B - 90%C、5%B - 95%C和2%B - 98%C(反之亦然)。4至5天后,获得可移植的表皮替代物,并移植到成年Balb/c或C3H/HeN雄性小鼠身上。受体总是接受含有较低比例自身角质形成细胞的异种移植物。在移植后第15天和第30天,与同种异体移植物相比,所有异种移植物均显示出显著的移植物存活(>75%)和皮肤替代。再生组织结构良好且血管化良好。这些组织仅含有同基因角质形成细胞。这些结果使我们质疑这是否是一种活跃的免疫状态。结构分析显示存在白细胞浸润,其取决于异种移植物中异基因角质形成细胞的百分比。然而,即使是2%同基因 - 98%异基因移植物,浸润也低于同种异体移植物。白细胞表型分析证实存在浸润异种移植物的免疫细胞,并揭示CD8 +和CD4 +淋巴细胞参与了这种免疫激活。这两种细胞群体的百分比低于同种异体移植物,表明与同种异体移植物相比,每次异种移植物后细胞激活程度适中。总之,即使是2%同基因 - 98%异基因异种移植物后也有可能生成功能性皮肤;与同种异体移植物相比,细胞免疫激活程度适中。